Over the past decade, cell, apheresis and gene therapies have progressed from experimental concepts to established components of routine clinical care. What once appeared to be an ‘overnight success’ has been built on decades of scientific discovery, clinical translation and system-level innovation. For patients with otherwise refractory disease – and for the donors whose generosity underpins some of these therapies – the impact has been transformative.
Also of interest
-
Tackling health inequalities – NHS Blood and Transplant Research and Development Conference, October 2023
A recent NHS conference explored inequalities in transfusion and organ donation.